Research Ethics Forum – serie

This is the first book on social science research ethics in an African context and an indispensable resource for researchers, students, policy makers and research institutions in or interested in African research ethics.

This is the first book on social science research ethics in an African context and an indispensable resource for researchers, students, policy makers and research institutions in or interested in African research ethics.

This volume is the first book-length study of disguised forms of plagiarism that mar the body of published research in humanities disciplines. As a contribution to applied research ethics, this practical guide offers a typology of the principal forms of disguised plagiarism.

This Open Access book provides illustrative case studies that explore various research and innovation topics that raise challenges requiring ethical reflection and careful policymaking responses.

This Open Access book provides illustrative case studies that explore various research and innovation topics that raise challenges requiring ethical reflection and careful policymaking responses.

The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​

This book discusses ‘how’ to respectfully and responsibly include pregnant women in clinical research. In sharp contrast, the existing literature predominantly focuses on the reasons ‘why’ the inclusion of pregnant women in clinical research is necessary – viz., to develop effective treatments for women during pregnancy, to promote fetal safety, to reduce harm to women and fetuses from suboptimal care, and to allow access to the benefits of research participation. This book supports the shift to a new default position, whereby pregnant women are included in clinical research unless researchers argue convincingly for their exclusion. This shift raises many as yet unexplored ethical and policy questions about existing barriers to the equitable inclusion of pregnant women in research.This book is original in three key ways. First, it presents an unparalleled depth of analysis of the ethics of research with pregnant women, bringing together many of the key authors inthis field as well as experts in research ethics and in vulnerability who have not previously applied their work to pregnant women. Second, it includes innovative theoretical work in ethics and disease specific case studies that highlight the current complexity and future challenges of research involving pregnant women. Third, the book brings together authors who argue both for and against including more pregnant women in formal clinical trials.

In this book,scholars with different disciplinary and national backgrounds argue forpossible answers and analyse case studies on current issues of governance inbiomedical research. These issues comprise among others the research-caredistinction, risk evaluation in early human trials, handling of incidentalfindings, nocebo effects, cluster randomized trials, publication bias, orconsent in biobank research. This book demonstrates how new technologies andresearch possibilities multiply or intensify already known governancechallenges, leaving room for ethical analysis and complex moral choices.Clinical researchers, research ethics committee members and research ethicistshave all to deal with such challenges on a daily basis. While generalreflection on core concepts of research ethics is seldom pointless, thoseconfronted with hard moral choices do need more practical and contextualizedreflection on the said issues. This book particularly provides suchcontextualized reflectionsand aims to inform all those who study, conduct,regulate, fund, or participate in biomedical research.

The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​

This book addresses the pressing issues involved with the ethical conduct of research in one developing world region – the Arab Region. Clinical research has soared in the developing world -as pharmaceutical companies continue their search for regions with large, treatment naive populations - including the Arab region, and has profound implications for the health and the economies for the area. The ethical issues involved with the conduct of such research, however, have so far not been adequately addressed. This volume presents the issues regarding research ethics and research governance that have relevance for health authorities, regulators, industry, and academia. As a multi-authored volume it includes both international and local experts on ethical issues in research, representing all stakeholders, thus presenting a balanced view on this timely topic.

This book discusses ‘how’ to respectfully and responsibly include pregnant women in clinical research. In sharp contrast, the existing literature predominantly focuses on the reasons ‘why’ the inclusion of pregnant women in clinical research is necessary – viz., to develop effective treatments for women during pregnancy, to promote fetal safety, to reduce harm to women and fetuses from suboptimal care, and to allow access to the benefits of research participation. This book supports the shift to a new default position, whereby pregnant women are included in clinical research unless researchers argue convincingly for their exclusion. This shift raises many as yet unexplored ethical and policy questions about existing barriers to the equitable inclusion of pregnant women in research.This book is original in three key ways. First, it presents an unparalleled depth of analysis of the ethics of research with pregnant women, bringing together many of the key authors inthis field as well as experts in research ethics and in vulnerability who have not previously applied their work to pregnant women. Second, it includes innovative theoretical work in ethics and disease specific case studies that highlight the current complexity and future challenges of research involving pregnant women. Third, the book brings together authors who argue both for and against including more pregnant women in formal clinical trials.

In this book,scholars with different disciplinary and national backgrounds argue forpossible answers and analyse case studies on current issues of governance inbiomedical research.

This book addresses the pressing issues involved with the ethical conduct of research in one developing world region – the Arab Region. This volume presents the issues regarding research ethics and research governance that have relevance for health authorities, regulators, industry, and academia.

This volume is the first book-length study on post-publication responses to academic plagiarism in humanities disciplines. It demonstrates that the correction of the scholarly literature for plagiarism is not a task for editors and publishers alone; each member of the research community has an indispensable role in maintaining the integrity of the published literature in the aftermath of plagiarism. If untreated, academic plagiarism damages the integrity of the scholarly record, corrupts the surrounding academic enterprise, and creates inefficiencies across all levels of knowledge production. By providing case studies from the field of philosophy and related disciplines, the volume exhibits that current post-publication responses to academic plagiarism are insufficient. It catalogues how humanities disciplines fall short in comparison with the natural and biomedical sciences for ensuring the integrity of the body of published research. This volume provides clarity about how to conceptualize the scholarly record, surveys the traditional methods for correcting it, and argues for new interventions to improve the reliability of the body of published research. The book is valuable not only to those in the field of philosophy and other humanities disciplines, but also to those interested in research ethics, meta-science, and the sociology of research.

The pilot-less drones, smart bombs and other high-tech weapons on display in recent conflicts are all the outcome of weapons research. However, the kind of scientific and technological endeavour has been around for a long time, producing not only the armaments of Nazi Germany and the atomic bombs dropped on Japan, but the catapults used in ancient Greece and Rome and the assault rifles used by child soldiers in Africa.  In this book John Forge examines such weapons research and asks whether it is morally acceptable to undertake such an activity. He argues that it is in fact morally wrong to take part in weapons research as its primary purpose is to produce the means to harm others, and moreover he argues that all attempts to then justify participation in weapons research do not stand up to scrutiny. This book has wide appeal in fields of philosophy and related areas, as well to a more general audience who are puzzled about the rate at which new weapons are accumulated.